1 enrolling by invitation, 1 unknown. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 1, Unknown 1 |
| Phase 2 | 2 | Enrolling by invitation 1, Unknown 1 |
Follow Menstrual Irregularities: new trials by email Literature Review of Menstrual Irregularities trials Research Report on Menstrual Irregularities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus Dulaglutide - Menstrual Irregularities, Type1 Diabetes Mellitus | Phase 1 / Phase 2 | Enrolling by invitation | Ain Shams University | 50 | 2025-08-04 | 2026-06-05 |
| Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism TAB METFORMIN, TAB PIOGLITAZONE - Menstrual Irregularities, Hyperandrogenism | Phase 1 / Phase 2 | Unknown | Dow University of Health Sciences | 110 | 2018-06-18 | 2018-11-29 |
Menstruation Disturbances (2) · Hyperandrogenism (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · 46, XX Disorders of Sex Development (1) · Adrenogenital Syndrome (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Disorders of Sex Development (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gonadal Disorders (1) · Male Urogenital Diseases (1) · Urogenital Abnormalities (1) · Urogenital Diseases (1)
Metformin (1) · Pioglitazone (1) · dulaglutide (1)
Ain Shams University (1) · Dow University of Health Sciences (1)
Egypt (1) · Pakistan (1)